Laurus Labs Ltd logo

Laurus Labs Ltd

NSE: LAURUSLABS BSE: 540222

₹2020

(0.83%)

Sat, 17 Oct 2026, 04:56 pm

mtf coin illustrationMTF 5xInvest in Laurus Labs Ltd with 5x LeverageBuy with MTFpremium button ring illustration
Market Cap (in Cr)110007.56
PE Ratio99.84
Dividend0.10
Health TechnologyHealth Technology
Pharmaceuticals: MajorPharmaceuticals: Major
24.5K24.5K

Laurus Labs Share Price Live Chart

1 Day

(0.83%)

No Result Found

Summary

  • Market Cap (in Cr)

    111898.66

  • Net Profit (in Cr)

    354.41

  • P/B

    10.10

  • Sector P/E

    36.69

  • P/E

    60.26

  • EV/EBITDA

    30.53

  • Debt/Equity (Industry)

    0.19

  • Interest Cover (Industry)

    13.14

  • ROCE (Industry)

    12.29

  • RONW (Industry)

    10.69

  • ROE

    7.36

  • ROCE

    8.80

  • Debt/Equity

    0.62

  • EPS (TTM)

    20.24

  • Dividend Yield

    0.10

  • Book Value

    98.09

  • Interest Cover

    2.98

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersJUN 2026MAR 2026DEC 2025SEPT 2025JUN 2025
Promoters27.4727.4927.4927.5927.59
FII28.0025.8226.5226.1625.70
DII13.7413.9712.4311.7311.94
Public30.7832.7133.5634.5134.77
Government00.000.000.000.00

Read More

Technical Analysis

RSI

60.45

MACD

36.67

50 DMA

1930.12

200 DMA

1403.21

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic2436.202192.602086.3019491842.701705.401461.80
Fibonacci2192.602099.542042.0619491855.941798.461705.40
Camarilla2046.992024.662002.3319491957.671935.341913.01

Pivots Level: Classic

R3

+487.20

2436.20

R2

+243.60

2192.60

R1

+137.30

2086.30

1949
1949
Pivot Point
LTP: 2060.10

S1

-106.30

1842.70

S2

-243.60

1705.40

S3

-487.20

1461.80

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    2033.45

  • 20-EMA

    2009.29

  • 30-EMA

    1980.32

  • 50-EMA

    1913.20

  • 100-EMA

    1744.79

  • 200-EMA

    1499.21

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
30 Apr 2026dividend₹1.20 Dividend /Share08 May 2026
30 Apr 2026board-meetingsAccounts, Quarterly Results, Interim Dividend
30 Apr 2026agm
23 Jan 2026board-meetingsQuarterly Results
23 Oct 2025dividend₹0.80 Dividend /Share31 Oct 2025
01 Oct 2025dividendInterim Dividend - Rs. - 0.831 Oct 2025
15 May 2025agm
24 Apr 2025dividend₹0.80 Dividend /Share09 May 2025
09 Apr 2025dividendInterim Dividend - Rs. - 0.809 May 2025
24 Oct 2024dividend₹0.40 Dividend /Share06 Nov 2024

Read More

Peer Comparison

Laurus Labs Ltd logo

Laurus Labs Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Read More

Laurus Labs Ltd About

Laurus Labs offers a broad and integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished Dosage Forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2005

Headquarters

CEO

Ravindranath Kancherla

Employees

Contact

Website icon

Website

http://www.lauruslabs.com

Email icon

Email

secretarial@lauruslabs.com; info@lauruslabs.com

Phone icon

Phone

91-891-3061222

Location icon

Location

Plot No 21 Jawaharlal Nehru, Pharma City Parawada, Visakhapatnam, Andhra Pradesh, 531021

Read More

Laurus Labs Ltd Company History

YearHistory
2020
  • Laurus Labs donates Hydroxychloroquine (HCQ) IP 200mg tablets & INR 50 lakhs fund to fight the COVID-19 pandemic in Telangana and Andhra Pradesh States.
  • Rising Pharmaceuticals and Laurus Labs Partner to Support the University of Minnesota to Explore the Prophylaxis Effect of Hydroxychloroquine in Essential Health Care Workers.
  • Laurus Labs enters the rapidly growing biotechnology segment by acquiring a majority stake in Richcore Lifesciences.
  • Laurus Labs' exclusive distribution partner Rising Pharmaceuticals, launches Pregabalin Capsules in US market.
2021
  • Laurus Labs wins coveted Golden Peacock Award for Excellence in Corporate Governance.
  • Laurus Labs receives the License to manufacture and market 2-Deoxy-D-Glucose (2DG) in India, from DRDO.
  • Laurus Labs Unitaid and the Clinton Health Access Initiative, announce agreement to accelerate development of best-in-class second- and third-line HIV medication for children.
  • Laurus Labs signs an agreement with MPP (Medicine Patient Pool) to manufacture Molnupiravir, oral COVID-19 antiviral medication.
  • Laurus Labs enters the rapidly growing biotechnology segment by acquiring a majority stake in Richcore Lifesciences.
2022
  • Laurus Labs received purchase orders from a leading Global Life Sciences Company.
2023
  • Laurus Labs received USFDA tentative approval for the World's First Paediatric ARV Oral Dispersible Film (ODF) drug, Dolutegravir 5mg and 10mg in HIV/AIDS treatment.
  • Laurus Labs signed Memorandum of Agreement (MOA) with IIT Kanpur for novel gene therapy assets.
2024
  • Laurus Labs inaugurates new State of the Art R&D facility at IKP Knowledge park.
  • Laurus Labs concludes successful USFDA Audit for API Manufacturing Facility at Hyderabad.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
BNP PARIBAS FINANCIAL MARKETSbulkSell62721751914.2831 Aug 2026
SOCIETE GENERALEbulkSell28104371903.8431 Aug 2026
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.bulkSell51343611914.0431 Aug 2026
BNP PARIBAS FINANCIAL MARKETSbulkBuy153991860.3531 Aug 2026
INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.bulkBuy17181922.6931 Aug 2026
GRAVITON RESEARCH CAPITAL LLPbulkSell3689009536.2327 Jan 2025
GRAVITON RESEARCH CAPITAL LLPbulkBuy3690709536.527 Jan 2025
CYBAGE SOFTWARE PRIVATE LIMITEDblockSell63589430514 Mar 2023
ARUN VIJAY NATHANIblockBuy63589430514 Mar 2023
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell529337455.414 Nov 2022

Read More

Laurus Labs Ltd News

Laurus Labs invests ₹1,078 crore in Krka Pharma

Laurus Labs invested ₹1,078 crore in Krka Pharma through a rights issue, acquiring 107.8 million shares in the pharmaceutical company.

14 Oct 2026

companies

Laurus Labs to host Q2 FY27 earnings call on Oct 29

Laurus Labs Ltd will conduct a conference call on October 29, 2026, at 5:00 pm IST to discuss its Q2 and H1 FY27 financial results, hosted by DAM Capital Advisors.

13 Oct 2026

companies

Laurus Labs shares flag large-trade signal on BSE

A large-trade signal flagged approximately 302,000 Laurus Labs shares changing hands on BSE at ₹2034.30, with a combined value of ₹61.44 crore.

08 Oct 2026

equity-markets

Laurus Labs invests ₹12.09 crore in Kurnool Renewables

Laurus Labs acquired 1.21 crore equity shares in Kurnool Renewables Private Limited for ₹12.09 crore via rights issue, maintaining its 26% stake.

06 Oct 2026

companies

Laurus Labs Q1FY27: Profit up 126%, EBITDA margin hits 31.8%

Laurus Labs reported a 126% YoY rise in net profit to ₹368 crore for Q1FY27, driven by strong CDMO growth and operational leverage. Revenue climbed 29% to ₹2,026 crore with EBITDA margins expanding by 700 bps.

18 Sept 2026

companies

Read More

Frequently Asked Questions

  • 1.What is the stock price of Laurus Labs Ltd?

    As of 17/10/2026 at 10:26 PM, Laurus Labs Ltd shares are trading at ₹2020.

  • 2.What is the market cap. of Laurus Labs Ltd?

    As of 17/10/2026, the market capitalization of Laurus Labs Ltd is ₹1,10,007.56 crore.

  • 3.When was Laurus Labs Ltd founded?

    Laurus Labs Ltd was founded in 2005.

  • 4.What are the P/E and P/B ratios of Laurus Labs Ltd?

    As of 17/10/2026, Laurus Labs Ltd has a P/E ratio of 99.84 and a P/B ratio of 10.10.

  • 5.How can I buy shares of Laurus Labs Ltd?

    You can buy shares of Laurus Labs Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.

  • 6.What is the shareholding pattern of Laurus Labs Ltd?

    As of June,2026, promoters hold 27.47% in Laurus Labs Ltd, while FIIs, DIIs and public shareholders hold 28.00%, 13.74% and 30.78%, respectively.

  • 7.Does Laurus Labs Ltd pay dividends?

    Yes, Laurus Labs Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹1.20 Dividend /Share per share.

  • 8.What is the dividend yield of Laurus Labs Ltd?

    As of 17 October, 2026, the dividend yield of Laurus Labs Ltd stands at 0.10%.

  • 9.What are the latest financial results of Laurus Labs Ltd?

    For January,2024, Laurus Labs Ltd reported revenue of ₹5,554.00 crore and a net profit of ₹358.00 crore.

  • 10.What is the Stock symbol of Laurus Labs Ltd?

    LAURUSLABS is the stock symbol of Laurus Labs Ltd.

  • 11.Who is the CEO of Laurus Labs Ltd?

    The CEO of Laurus Labs Ltd is Ravindranath Kancherla.

pocketful logo lightpocketful logo dark
PricingBecome a Partner
search icon
/

No results for ''

Popular search

  • popular search iconSuzlon Energy Ltd
  • popular search iconIndian Railway Finance Corporation Ltd
  • popular search iconTata Motors Ltd
  • popular search iconTata Steel Ltd
  • popular search iconRail Vikas Nigam Ltd

Recent search

      Log In
      search icon

      No results for ‘’

        Popular search

        • popular search iconSuzlon Energy Ltd
        • popular search iconIndian Railway Finance Corporation Ltd
        • popular search iconTata Motors Ltd
        • popular search iconTata Steel Ltd
        • popular search iconRail Vikas Nigam Ltd
        • popular search iconReliance Industries Ltd
        pocketful logo lightpocketful logo dark
        • Pricing
        • Become a Partner
        Log In
        • home icon
        • arrow iconstocks
        • arrow iconlaurus labs ltd
        • Overview
        • Analysis
        • Financials
        • Ratios
        • shareholding
        • Technical Analysis
        • Corporate Actions
        • Peer Comparison
        • About
        • Company History
        • Deals
        • News
        • FAQs

        Open Your Free Demat Account Now!

        Step into a world of zero fees and limitless opportunities!

        pocketful logo
        • Quick Links

          • Open Demat Account
          • Pocketful Web
          • Pocketful App
          • Pricing
          • Authorised Person
          • Pocketful Calculators
          • Compliance Links
        • Pages

          • Tools
          • Blogs
          • ETF Screener
          • IPO
          • ETF
          • Bonds
          • Index Heat Map
        • Products

          • Stocks
          • Commodity
          • Subscription
          • Free Stock Screener
          • Pocketful GPT
          • MTF
          • Mutual Funds
        • Company

          • About us
          • Contact us
          • Terms and Conditions
          • Policies & Procedures
          • Privacy Policy
          • Disclosure
          • Careers
        • Socials

          • Facebook iconFacebook
          • Twitter iconTwitter
          • Instagram iconInstagram
          • LinkedIn iconLinkedIn
          • Youtube iconYoutube

        2022-25 Pocketful. All rights reserved, Built with in India

        Version -5.76

        app image 1app image 2

        Stocks:

        AllABCDEFGHIJKLMNOPQRSTUVWXYZ

        Explore

        Calculators
        Popular Calculators
        Group Stocks
        Asset Management Companies
        Popular Stocks
        Indian Indices
        Sector Wise Stocks
        IPO
        Share Market
        Best MF Schemes
        Platforms
        Resources
        Gold Rates in Top Cities
        Silver Rates in Top Cities

        Others:

        NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

        Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800